Barclays Initiates Coverage On Medtronic with Equal-Weight Rating, Announces Price Target of $95

Benzinga Newsdesk www.benzinga.com Neutral 57.0%

Neg 0% Neu 57% Pos 0%

Barclays analyst Christopher Pasquale initiates coverage on Medtronic (NYSE:MDT) with a Equal-Weight rating and announces Price Target of $95.